Glucocorticoid intracellular metabolism, catalyzed by the two isozymes of 11 -hydroxysteroid dehydrogenase (11 -HSD), determines the corticosteroid action on target tissues.
1 11 -HSD1
functions as a reductase in most cells and catalyzes the regeneration of active glucocorticoids thereby amplifying their action. This isozyme is wildely expressed in liver, adipose tissue, muscle, pancreatic islets, and adult brain. 11 -HSD2 is a high-affinity dehydrogenase and inactivates cortisol and corticosterone to the inert product, cortisone. Cortisone in turn can be reactivated through reduction by 11 -HSD1 (Figure 1) . The 11 -HSD2 isozyme is highly expressed in the distal nephron and, as we learn here, in the nucleus tractus solitarius (NTS). 11
-HSD2 serves to protect the mineralocorticoid receptor (MR) from occupation by cortisol or corticosterone ( Figure 2 ).
The development of this complicated arrangement of receptors and steroid ligands has
been elucidated by molecular evolutionary biologists. The vertebrate ancestral corticoid receptor has been tracked back to 450 million years ago, its sequence has been "resurrected", and crystallized. 2 Investigators have identified the specific set of historical mutations occuring during evollution that recapitulated the GR's hormone specificity for corisol from an MR-like ancestor, suggesting that back then salt was more important than sugar. Interestingly, the MR is older than the GR.
In mammals, the adrenal cortex synthesizes aldosterone, the major mineralocorticoid, from the zona glomerulosa and the glucocorticoids, cortisol and corticosterone, from the zona fasciculata and zona reticularis. Hsd11b2BKO and control mice. When salt was withdrawn, the blood pressure increase disappeared within one week. When given spironolactone, the salt preference of Hsd11b2BKO was reduced by about 30%. The authors gave Hsd11b2BKO and control mice exposed to salt dexamethasone to reduce endogenous glucocorticoid production. This maneuver raised blood pressure in contol mice but had little influence on blood pressure of Hsd11b2BKO. The authors could detect no volume expansion or failure in salt elimination in Hsd11b2BKO subjected to a high-salt intake. However, pressor responses to phenylephrine were enhanced and resultant baroreflex regulation was impaired in the mice.
What are the implications of these findings? The authors suggest that 11 -HSD2 neurons must exist that integrate salt appetite and blood pressure via an MR-dependent pathway. . Wh Wh W en en en s s sal lt t t wa wa was w wit th hdraw aw awn, n, n, t t the e e b b blo o ood od od p p pre re ressure e e in in incr cr crease e e di di disa a app p p eared wi w th hin n on n ne week k k. When n n gi i iv ven s s spi i ironol olacto to one ne ne, th th the sa a alt t t prefe fe fer renc c ce of H H Hsd sd sd11b2 b2 2 f BK K KO O was redu d ced by y about 30%. The authors g gave Hsd11b2BKO and control mice exposed to salt barrier? Corticosteroid analogs are highly lipophilic and presumably cross cell membranes;
however, there is a role for membrane transporters, such as ABCB1, the multidrug-resistant/pglycoprotein that is particularly effective at the blood-brain barrier. For instance, the pglycoprotein minimises the access of dexamethasone into the brain. 7 The spironolactone active metabolite, canrenone, has been studied in detail and crosses the blood-brain barrier fairly well. 8 The authors implanted a 30 mg spironolactone subcutaneously into their mice. Any similarity to doses used in humans is uncertain, although the present findings are suffiently stimulating to warrant studies on salt appetite in humans. 9 The presence of an enzymatic mechanism protecting the MR and the effects on salt appetite and blood pressure with its absence, underscores the notion that aldosterone regulates salt appetite independent of angiotensin II-related effects. The data also have relevance to salt resistance, since the mice with an intact enzymatic barrier could increase their salt intake fivefold without effects on blood pressure. Aldosterone is believed to activate the same signaling and effector mechanisms in the brain as in the kidney including the MR, the serum and glucocorticoid-induced kinase SGK1, the ubiquitin ligase NEDD4-2, and the epithelial sodium channel ENaC. 10 The latter also mediates the gustatory salt sensing in the tongue, which is required for the manifestation of increased salt intake. Effects of aldosterone on both the brain and kidney synergize with the effects of angiotensin II. Thus, the current findings provide a unifying connection between MR activation in the central nervous system, salt appetite, and blood pressure regulation.
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Since the GR has a 10-fold lower affinity for cortisol than the MR, 11 -HSD1 provides a dynamic range for amlplification to impact signaling events. 
